Description de l'entreprise
DocMorris AG is one of Europe's leading online pharmacy and one of Switzerland's foremost wholesale suppliers to medical practitioners. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management in order to increase therapy safety. The creation of added value and a pronounced patient orientation company as an important strategic partner for service providers, cost units and industry.
Conseil d'administration & Conseil de surveillance
| PDG |
| Walter Hess |
| Conseil d'administration |
| Daniel Wüest, Madhu Nutakki, Kaspar Niklaus, David Masó |
| Conseil de surveillance |
| Walter Oberhänsli, Prof. Stefan Feuerstein, Prof. Dr. Andréa Belliger, Rongrong Hu, Dr. Christian Mielsch, Florian Seubert |
Données de l'entreprise
| Nom: |
DocMorris AG |
| Adresse: |
Walzmühlestrasse 49,CH-8500 Frauenfeld |
| Téléphone: |
- |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
https://corporate.docmorris.com/de/ |
| Industrie: |
Consumer Goods |
| Secteur: |
Retailers |
| Sous-secteur: |
- |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
06/07/2017 |
Relations avec les investisseurs
| Nom: |
Dr. Daniel Grigat |
| Téléphone IR: |
+41 52 560 58 10 |
| IR-Fax: |
- |
| E-mail IR: |
ir@docmorris.com
|
